staurosporine has been researched along with minocycline in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Dong, Z; Hess, DC; Hill, WD; Wang, CY; Wang, J; Wei, Q | 1 |
| Bantubungi, K; Blum, D; Brotchi, J; Brouillet, E; Chtarto, A; Déglon, N; Galas, MC; Greco, A; Jacquard, C; Levivier, M; Minghetti, L; Pintor, A; Popoli, P; Schiffmann, SN; Tai, K; Tenenbaum, L | 1 |
| Aguirre, N; Ceña, V; Fernandez-Gomez, FJ; Galindo, MF; Gomez-Lazaro, M; González-García, C; Jordán, J | 1 |
| Anderton, BH; Garwood, C; Hanger, DP; Kinsey, AM; Noble, W; Stephenson, J | 1 |
| Kawahara, I; Kinugawa, S; Kobayashi, Y; Koide, M; Mizoguchi, T; Muto, A; Nakamura, M; Ninomiya, T; Takahashi, N; Udagawa, N; Yasuda, H | 1 |
6 other study(ies) available for staurosporine and minocycline
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Caspases; Cell Death; Cells, Cultured; Cisplatin; Cytosol; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Epithelial Cells; Hypoxia; In Situ Nick-End Labeling; Ischemia; Kidney; Male; Membrane Proteins; Microscopy, Fluorescence; Minocycline; Mitochondria; Oligonucleotides, Antisense; Precipitin Tests; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium Azide; Staurosporine; Subcellular Fractions; Time Factors; Up-Regulation | 2004 |
Minocycline in phenotypic models of Huntington's disease.
Topics: Animals; Calpain; Caspases; Cell Death; Cells, Cultured; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Glutamic Acid; Huntingtin Protein; Huntington Disease; Male; Minocycline; Nerve Degeneration; Nerve Tissue Proteins; Neuroprotective Agents; Nitro Compounds; Nuclear Proteins; Phenotype; Propionates; Quinolinic Acid; Rats; Rats, Inbred Lew; Rats, Wistar; Staurosporine | 2005 |
Involvement of mitochondrial potential and calcium buffering capacity in minocycline cytoprotective actions.
Topics: Animals; Calcium; Cell Count; Cell Death; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Glutathione; Humans; Membrane Potentials; Minocycline; Mitochondria; Mitochondrial Swelling; NADP; Neuroblastoma; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Spectrophotometry; Staurosporine; Tetrazolium Salts; Thiazoles | 2005 |
Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Caspase 3; Cell Death; Cells, Cultured; Glutamic Acid; Humans; Mice; Mice, Transgenic; Minocycline; Neurons; Rats; Staurosporine; tau Proteins; Time Factors | 2009 |
Tetracyclines convert the osteoclastic-differentiation pathway of progenitor cells to produce dendritic cell-like cells.
Topics: Animals; B7-2 Antigen; Bone Resorption; CD11c Antigen; Cell Differentiation; Cell Proliferation; Cells, Cultured; Dendritic Cells; Doxycycline; Enzyme Inhibitors; Granulocyte-Macrophage Colony-Stimulating Factor; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Minocycline; Mitogen-Activated Protein Kinases; NF-kappa B; Osteoclasts; Phagocytosis; Proto-Oncogene Proteins c-fos; RANK Ligand; Signal Transduction; STAT5 Transcription Factor; Staurosporine; Stem Cells | 2012 |